SARS

Ann Arbor Biosciences To Sell New COVID-19 Test – Up To 1M A Day

ANN ARBOR—Officials of Swift Biosciences, a developer of gene sequencing technology, and BillionToOne, a Menlo Park, Calif. diagnostics company, announced that Swift Bioscience will be the exclusive distributor of BillionToOne’s RNA extraction-free, Emergency Use Authorization (EUA) COVID-19 Test Kit for high capacity testing of up to a million tests per day. The test is designed to detect

By |2020-10-04T20:31:50-04:00October 4th, 2020|ESD, Life Sciences, Life Sciences/Biotech|

Ann Arbor Biotech Companies Form Partnership To Battle SARS

ANN ARBOR—Swift Biosciences and Arbor Biosciences, two Ann Arbor biotech companies, have partnered to offer a complete workflow for RNA-Seq library preparation and targeted enrichment of the SARS-CoV-2 genome. An enabling offering for epidemiological research and public health surveillance, the partnership uses Swift’s patented Adaptase technology within the Swift RNA Library Kits combined with myBaits

By |2020-06-06T15:31:52-04:00June 6th, 2020|Coronavirus, Science|